Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-25 @ 2:11 AM
NCT ID:
NCT05681260
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed T-lineage lymphoblastic lymphoma (T-LBL) Stage II-IV
Exclusion Criteria:
* Patients with Down syndrome or primary immune comprised disease.
* Ph+ T-LBL
* Patients must not have received any prior cytotoxic chemotherapy
* Any steroids pretreatment for \> 5 days in the 7 days or for \>14 days in the 28 days before the initiation of Induction chemotherapy. The dose of prednisone or methylprednisone pretreatment does not affect eligibility. Any steroids exposure that occurred \> 28 days before the initiation of Induction chemotherapy is allowed. Inhalation and topical steroids are not considered pretreatment. A single dose of vincristine is allowed.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
18 Years
Study:
NCT05681260
Study Brief:
Protocol Section:
NCT05681260